Segall Bryant & Hamill’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.9M Sell
1,325,156
-980,342
-43% -$23.1M 0.4% 58
2026
Q1
$34.5M Buy
2,305,498
+1,198,020
+108% +$20.4M 0.49% 47
2025
Q4
$16.1M Buy
+1,107,478
New +$19.3M 0.22% 164

Other funds holding CORZ

Segall Bryant & Hamill's CORZ Position: Q2 2026 in Review

Segall Bryant & Hamill reduced its Core Scientific (CORZ) stake by 43% in Q2 2026, selling an estimated $23.1M and leaving 1,325,156 shares worth $33.9M. The position accounts for 0.4% of the portfolio, ranked #58.

Segall Bryant & Hamill first reported a position in CORZ in Q4 2025 and has held it in 3 quarters since. The position peaked at $34.5M in Q1 2026. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Segall Bryant & Hamill held 1,325,156 shares of Core Scientific worth $33.9M as of Q2 2026.
  • Segall Bryant & Hamill sold 980,342 Core Scientific shares in Q2 2026, an estimated $23.1M.
  • Core Scientific made up 0.4% of Segall Bryant & Hamill's portfolio in Q2 2026, its #58 holding.
  • Segall Bryant & Hamill first reported a position in Core Scientific in Q4 2025 and has held it in 3 quarters since.
  • Segall Bryant & Hamill's Core Scientific position peaked at $34.5M in Q1 2026.
  • 413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.